Clinical Trial Update: Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKI [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating toripalimab plus pemetrexed and platinum in advanced non-small cell lung cancer previously treated with EGFR-TKI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)
• Toripalimab (Toripalimab)
• platinus (platinum-based chemotherapy (platinum))

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: UNKNOWN